NCT06671639Recruiting
Stanford Program to Accelerate Robotic Children's Surgery
Source: ClinicalTrials.gov · Last updated 30 Apr 2026
Brief summary (registry, in English)
The goal of this clinical trial is to provide additional data to confirm safety and performance of the da Vinci Xi Surgical System in a human clinical setting. This pilot study is intended to provide an initial assessment to evaluate the feasibility, safety, and effectiveness for the utilization of the da Vinci Xi on pediatric and adolescent patients. This clinical trial will be conducted under the auspices of Stanford University's IRB approval.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- First submitted
- 31 Oct 2024
- Start date
- 1 Aug 2025
- Primary completion date
- 28 Feb 2027
- Lead sponsor
- Stanford University
- Diseases
- Endometriosis
- NCT number
- NCT06671639
What you commit to
- Study type: Interventional
- Planned participants: 250
- From 1 Aug 2025 to the primary completion date, 28 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subject is contraindicated for general anesthesia or surgery
Other illness
- Subject is mentally handicapped or has a psychological disorder or severe systemic illness that would preclude compliance with study requirements or ability to provide informed consent
Other
- Subject with uncorrected coagulopathy
- Subject has clinical requirement for primary open operative procedure
- Subject is ASA 4 or 5 status
- Subject is pregnant or suspected to be pregnant
Who the study is looking for
- Subject is between 6 - 21 years of age (weighing at least 15 kilograms)
- Subject clinically diagnosed with a medical condition for which one of the study procedures is appropriate therapy and selected as the treatment of choice by the guardian and surgeon.
- Subject without previous treatment using a robotic surgery device
- Subject or their guardian is willing and able to provide written informed consent
- Subject or their guardian is willing and able to comply with the study protocol requirements
Age in the registry: 6 years to 21 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Lucile Packard Children's Hospital Stanford Coordinator of this site? Confirm its status | Stanford | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.